Governor nominates new UNM regents
Nominees unanimously approved by New Mexico Senate March 15, 2021
Gov. Michelle Lujan Grisham has announced the nomination of three appointments to The University of New Mexico Board of Regents including Jack Fortner, William “Bill” Payne and Randy Ko. The nominees were submitted to the Senate Rules Committee for appointment and were approved unanimously in the Senate Rules Committee and were confirmed unanimously by the New Mexico Senate on Friday, March 12.
Fortner and Payne were appointed to six-year terms, while Ko, a student regent, was appointed for two years. Their terms end Dec. 31, 2026, and Dec. 31, 2022, respectively. They replace Regents Rob Doughty, Marron Lee and student-regent Melissa Henry, whose terms expired Dec. 2020.
DOE Nanoscale Science Research Centers Support QIS Research to Advance Energy, Economic, and National Security
DOE/US Department of Energy
WASHINGTON, D.C. - The U.S. Department of Energy (DOE) today announced plans to provide $30 million for Quantum Information Science (QIS) research that helps scientists understand how nature works on an extremely small scale 100,000 times smaller than the diameter of a human hair. QIS can help our nation solve some of the most pressing and complex challenges of the 21st century, from climate change to national security. Watch this video to learn more about QIS. Quantum computing and devices are poised to revolutionize the way we process information and develop new technologies that are currently beyond our reach, said Secretary of Energy Jennifer M. Granholm. From developing novel materials to building better batteries to moving clean electricity across the country more efficiently, the field of quantum information sciences can help us accel
Share this article
Share this article
JUPITER, Fla., Feb. 1, 2021 /PRNewswire/ Marizyme, Inc. (OTCQB:MRZM), a publicly traded global biotechnology company developing products to reduce the burden of ischemia-reperfusion injury in tissue grafting, organ transplant, and other surgical indications, announced today that it has added two life science industry veterans to its senior management team. Roger Schaller has been appointed Executive Vice President (EVP) of Commercial Operations, and Amy Chandler has been promoted to Executive Vice President (EVP) for Regulatory Affairs and Quality Management Systems. Mr. Schaller s extensive experience overseeing commercial operations, business development and successful product development will be a tremendous asset to Marizyme as we focus on advancing commercial operations and revenue generation in the year ahead, said Dr. Neil J. Campbell, Marizyme s CEO, President and Board Member. His expertise will be invaluable in building Marizym